TScan Therapeutics TCRX
NASDAQ TCRX
$0.32 +0.00 (+0.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Return on Assets [ROA] (2021 - 2026)

Updated

TScan Therapeutics' Return on Assets [ROA] was -63.04% in Q2 2026, down 20.05 percentage points from -42.99% a year earlier and down 5.33 percentage points from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at TScan Therapeutics came in at -43.26%, down 3.96 percentage points from FY2024.

  • Return on Assets [ROA] has now declined for three consecutive years, with a four-year change of -2.37 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Assets [ROA] was -39.30% in FY2024 (-1.44 pp), -37.87% in FY2023 (-3.66 pp), -34.21% in FY2022 (+6.68 pp) and -40.89% in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] in data going back to Q3 2021.
  • Compared with a year earlier, Return on Assets [ROA] has declined for five straight quarters, with an average year-over-year change of -11.46 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2023 (a gain of 9.78 percentage points); the worst was Q1 2026 (a drop of 20.66 percentage points).
  • Per Business Quant data, TCRX's Return on Assets [ROA] in the three quarters before Q2 2026 was -57.71% (Q1 2026), -52.86% (Q4 2025) and -50.47% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 10.47%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 4.65%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 28.37%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.10%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 9.29%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -6.13%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 2.14%
10 TScan Therapeutics 41.58 Mn 41.58 Mn - -63.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -63.04%
Mar 31, 2026 -57.71%
Dec 31, 2025 -52.86%
Sep 30, 2025 -50.47%
Jun 30, 2025 -42.99%
Mar 31, 2025 -37.05%
Dec 31, 2024 -35.16%
Sep 30, 2024 -30.79%
Jun 30, 2024 -33.92%
Mar 31, 2024 -37.74%
Dec 31, 2023 -31.66%
Sep 30, 2023 -29.04%
Jun 30, 2023 -33.26%
Mar 31, 2023 -38.98%
Dec 31, 2022 -36.33%
Sep 30, 2022 -38.82%
Jun 30, 2022 -38.23%
Mar 31, 2022 -31.92%
Dec 31, 2021 -24.75%
Sep 30, 2021 -25.22%
API Access

TScan Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TCRX&period=max&api_key=YOUR_API_KEY